首页> 外文期刊>World Allergy Organization Journal >World Allergy Organization Guidelines for the Assessment and Management of Anaphylaxis
【24h】

World Allergy Organization Guidelines for the Assessment and Management of Anaphylaxis

机译:世界过敏组织过敏反应评估和管理指南

获取原文
           

摘要

The illustrated World Allergy Organization (WAO) Anaphylaxis Guidelines were created in response to absence of global guidelines for anaphylaxis. Uniquely, before they were developed, lack of worldwide availability of essentials for the diagnosis and treatment of anaphylaxis was documented. They incorporate contributions from more than 100 allergy/immunology specialists on 6 continents. Recommendations are based on the best evidence available, supported by references published to the end of December 2010. The Guidelines review patient risk factors for severe or fatal anaphylaxis, co-factors that amplify anaphylaxis, and anaphylaxis in vulnerable patients, including pregnant women, infants, the elderly, and those with cardiovascular disease. They focus on the supreme importance of making a prompt clinical diagnosis and on the basic initial treatment that is urgently needed and should be possible even in a low resource environment. This involves having a written emergency protocol and rehearsing it regularly; then, as soon as anaphylaxis is diagnosed, promptly and simultaneously calling for help, injecting epinephrine (adrenaline) intramuscularly, and placing the patient on the back or in a position of comfort with the lower extremities elevated. When indicated, additional critically important steps include administering supplemental oxygen and maintaining the airway, establishing intravenous access and giving fluid resuscitation, and initiating cardiopulmonary resuscitation with continuous chest compressions. Vital signs and cardiorespiratory status should be monitored frequently and regularly (preferably, continuously). The Guidelines briefly review management of anaphylaxis refractory to basic initial treatment. They also emphasize preparation of the patient for self-treatment of anaphylaxis recurrences in the community, confirmation of anaphylaxis triggers, and prevention of recurrences through trigger avoidance and immunomodulation. Novel strategies for dissemination and implementation are summarized. A global agenda for anaphylaxis research is proposed.
机译:说明性的世界过敏组织(WAO)过敏反应指南是针对缺乏全球过敏反应指南而创建的。独特的是,在它们被开发出来之前,已证明缺乏全球范围的诊断和治疗过敏反应的必需品。他们汇集了来自六大洲的100多位过敏/免疫学专家的贡献。这些建议基于现有的最佳证据,并得到2010年12月底发布的参考文献的支持。该指南审查了严重或致命过敏反应的患者风险因素,放大过敏反应的辅助因素以及易感患者(包括孕妇,婴儿)的过敏反应,老年人以及患有心血管疾病的人。他们专注于迅速进行临床诊断的最高重要性,以及迫切需要的基本初始治疗,即使在资源贫乏的环境中也应有可能。这涉及制定书面紧急协议并定期进行演练;然后,一旦诊断出过敏反应,立即并同时寻求帮助,肌肉注射肾上腺素(肾上腺素),并将患者置于背部或下肢抬高的舒适位置。如果有指示,则其他至关重要的步骤包括给予补充氧气和维持呼吸道,建立静脉通道并进行液体复苏以及在连续按压胸部的情况下进行心肺复苏。应当定期并定期(最好是连续地)监测生命体征和心肺状况。该指南简要回顾了基本初始治疗中难治性过敏反应的管理。他们还强调要做好患者自我治疗的准备,以预防社区中的过敏反应复发,确认过敏反应触发因素,并通过避免触发因素和免疫调节来预防复发。总结了新的传播和实施策略。提出了过敏反应研究的全球议程。

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号